LAMOTRIGINE CH lamotrigine 200 mg dispersible/chewable tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

lamotrigine ch lamotrigine 200 mg dispersible/chewable tablets blister pack

amneal pharma australia pty ltd - lamotrigine, quantity: 200 mg - tablet, dispersible - excipient ingredients: povidone; microcrystalline cellulose; magnesium stearate; polacrilin potassium; sucralose; magnesium carbonate hydrate; flavour - lamotrigine is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children.,there is extensive experience with lamotrigine used initially as ?add-on? therapy. the use of lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs.,initial monotherapy treatment in newly diagnosed paediatric patients is not recommended.

LAMOTRIGINE CH lamotrigine 25 mg dispersible/chewable tablets bottle Australia - English - Department of Health (Therapeutic Goods Administration)

lamotrigine ch lamotrigine 25 mg dispersible/chewable tablets bottle

amneal pharma australia pty ltd - lamotrigine, quantity: 25 mg - tablet, dispersible - excipient ingredients: magnesium stearate; povidone; sucralose; magnesium carbonate hydrate; microcrystalline cellulose; polacrilin potassium; flavour - lamotrigine is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children.,there is extensive experience with lamotrigine used initially as ?add-on? therapy. the use of lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs.,initial monotherapy treatment in newly diagnosed paediatric patients is not recommended.

MUNATREP 5 lamotrigine 5 mg dispersible/chewable tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

munatrep 5 lamotrigine 5 mg dispersible/chewable tablets blister pack

arrotex pharmaceuticals pty ltd - lamotrigine, quantity: 5 mg - tablet, dispersible - excipient ingredients: microcrystalline cellulose; magnesium carbonate hydrate; magnesium stearate; povidone; sucralose; polacrilin potassium; flavour - lamotrigine is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children.,there is extensive experience with lamotrigine used initially as ?add-on? therapy. the use of lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs.,initial monotherapy treatment in newly diagnosed paediatric patients is not recommended.

LAMOTRIGINE CH lamotrigine 50 mg dispersible/chewable tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

lamotrigine ch lamotrigine 50 mg dispersible/chewable tablets blister pack

amneal pharma australia pty ltd - lamotrigine, quantity: 50 mg - tablet, dispersible - excipient ingredients: microcrystalline cellulose; polacrilin potassium; magnesium carbonate hydrate; povidone; sucralose; magnesium stearate; flavour - lamotrigine is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children.,there is extensive experience with lamotrigine used initially as ?add-on? therapy. the use of lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs.,initial monotherapy treatment in newly diagnosed paediatric patients is not recommended.

LAMOTRIGINE CH lamotrigine 100 mg dispersible/chewable tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

lamotrigine ch lamotrigine 100 mg dispersible/chewable tablets blister pack

amneal pharma australia pty ltd - lamotrigine, quantity: 100 mg - tablet, dispersible - excipient ingredients: magnesium carbonate hydrate; microcrystalline cellulose; povidone; sucralose; magnesium stearate; polacrilin potassium; flavour - lamotrigine is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children.,there is extensive experience with lamotrigine used initially as ?add-on? therapy. the use of lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs.,initial monotherapy treatment in newly diagnosed paediatric patients is not recommended.

MUNATREP 100 lamotrigine 100 mg dispersible/chewable tablets bottle Australia - English - Department of Health (Therapeutic Goods Administration)

munatrep 100 lamotrigine 100 mg dispersible/chewable tablets bottle

arrotex pharmaceuticals pty ltd - lamotrigine, quantity: 100 mg - tablet, dispersible - excipient ingredients: sucralose; povidone; microcrystalline cellulose; magnesium stearate; magnesium carbonate hydrate; polacrilin potassium; flavour - lamotrigine is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children.,there is extensive experience with lamotrigine used initially as ?add-on? therapy. the use of lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs.,initial monotherapy treatment in newly diagnosed paediatric patients is not recommended.

LAMOTRIGINE CH lamotrigine 5 mg dispersible/chewable tablets bottle Australia - English - Department of Health (Therapeutic Goods Administration)

lamotrigine ch lamotrigine 5 mg dispersible/chewable tablets bottle

amneal pharma australia pty ltd - lamotrigine, quantity: 5 mg - tablet, dispersible - excipient ingredients: polacrilin potassium; povidone; sucralose; magnesium stearate; magnesium carbonate hydrate; microcrystalline cellulose; flavour - lamotrigine is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children.,there is extensive experience with lamotrigine used initially as ?add-on? therapy. the use of lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs.,initial monotherapy treatment in newly diagnosed paediatric patients is not recommended.

LAMOTRIGINE CH lamotrigine 200 mg dispersible/chewable tablets bottle Australia - English - Department of Health (Therapeutic Goods Administration)

lamotrigine ch lamotrigine 200 mg dispersible/chewable tablets bottle

amneal pharma australia pty ltd - lamotrigine, quantity: 200 mg - tablet, dispersible - excipient ingredients: magnesium carbonate hydrate; microcrystalline cellulose; magnesium stearate; polacrilin potassium; sucralose; povidone; flavour - lamotrigine is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children.,there is extensive experience with lamotrigine used initially as ?add-on? therapy. the use of lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs.,initial monotherapy treatment in newly diagnosed paediatric patients is not recommended.

MUNATREP 25 lamotrigine 25 mg dispersible/chewable tablets bottle Australia - English - Department of Health (Therapeutic Goods Administration)

munatrep 25 lamotrigine 25 mg dispersible/chewable tablets bottle

arrotex pharmaceuticals pty ltd - lamotrigine, quantity: 25 mg - tablet, dispersible - excipient ingredients: povidone; polacrilin potassium; sucralose; microcrystalline cellulose; magnesium stearate; magnesium carbonate hydrate; flavour - lamotrigine is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children.,there is extensive experience with lamotrigine used initially as ?add-on? therapy. the use of lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs.,initial monotherapy treatment in newly diagnosed paediatric patients is not recommended.

REEDOS 25 lamotrigine 25 mg dispersible/chewable tablets bottle Australia - English - Department of Health (Therapeutic Goods Administration)

reedos 25 lamotrigine 25 mg dispersible/chewable tablets bottle

strides pharma science pty ltd - lamotrigine, quantity: 25 mg - tablet, dispersible - excipient ingredients: microcrystalline cellulose; polacrilin potassium; sucralose; magnesium stearate; povidone; magnesium carbonate hydrate; flavour - lamotrigine is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children.,there is extensive experience with lamotrigine used initially as ?add-on? therapy. the use of lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs.,initial monotherapy treatment in newly diagnosed paediatric patients is not recommended.